Published Date: 08 Apr 2024
"Disrespectful relative of palliative care" requires increased funding, support, and acceptance.
Read Full NewsCuda discussed the potential of the NIH toolbox to easily assess cognitive effects in clinical trials.
Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.
New findings from the LUMINA trial reveal AMX0114's safety in ALS patients, paving the way for further research and potential treatment advancements.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on neuromodulation for Parkinson disease!
Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors
Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia
Teva Pharmaceuticals Submits NDA on TEV-‘749 for Schizophrenia to the FDA
1.
Charles III, King of Kings, is Cancerous.
2.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
3.
Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models
4.
Study offers clearer picture of childhood brain tumor survival
5.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
1.
Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes
2.
From Muscle Soreness to Improved Endurance: The Benefits of Monitoring Lactic Acid Levels
3.
Breaking Down Amyloidosis: Understanding the Disease
4.
Beyond Immunotherapy: Emerging Novel Treatments for Small Cell Lung Cancer
5.
Targeting Oncology: Expanding Combinatorial Strategies by 2025
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
2.
Navigating the Complexities of Ph Negative ALL - Part V
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Updates on the First Line Management of ALK+ NSCLC
5.
Understanding the causes of anemia in adults beyond nutritional deficiencies
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation